A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients G. Moreno; M. Ruiz-Botella; I. Martín-Loeches; J. Gómez Álvarez; M. Jiménez Herrera; M. Bodí; F. Armestar; A. Marques Parra; Á. Estella; S. Trefler; R. Jorge García; J. Murcia Paya; P. Vidal Cortes; E. Díaz; R. Ferrer; A. Albaya-Moreno; L. Socias-Crespi; J.M. Bonell Goytisolo; S. Sancho Chinesta; A. Loza; L. Forcelledo Espina; J.C. Pozo Laderas; M. deAlba-Aparicio; L. Sánchez Montori; I. Vallverdú Perapoch; V. Hidalgo; V. Fraile Gutiérrez; A.M. Casamitjana Ortega; F. Martín Serrano; M. Nieto; M. Blasco Cortes; J. Marín-Corral; J. Solé-Violán; A. Rodríguez;

Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients G. Moreno; R. Carbonell; M. Bodí; A. Rodríguez;

Multidisciplinary approach of the sequelae one month after hospital discharge in patients with severe bilateral COVID-19 pneumonia, are there differences depending on the respiratory therapy used during admission to intensive care? A.M. Sánchez-García; P. Martínez-López; A.M. Gómez-González; J. Rodriguez-Capitán; R.J. Jiménez-López; J.M. García Almeida; E. Avanesi-Molina; N. Zamboschi; C. Rueda-Molina; V. Doncel-Abad; A.I. Molina-Ramos; E. Cabrera-César; I. Ben-Abdellatif; M. Gordillo-Resina; E. Pérez-Mesa; M. Nieto-González; P. Nuevo-Ortega; C. Reina-Artacho; P.L. Sánchez Fernández; M.F. Jiménez-Navarro; M.A. Estecha-Foncea;